Scientists are studying people intentionally exposed to the virus that causes COVID and those who don’t get sick to find out why some avoid infection.
Author: Karen Weintraub, USA TODAY
Federal agencies authorize second COVID-19 booster shot for Americans 50 and older
A second booster shot of the Pfizer or Moderna COVID-19 vaccine is allowed for those 50 and up. Immunocompromised can now get a fifth shot.
Pfizer-BioNTech requests FDA authorization for fourth COVID vaccine shot for 65 and older
It’s not clear how long the Food and Drug Administration will take to review the request or whether it will convene its expert panel to review it.
Depression, anxiety may linger for bedridden COVID patients but milder infections reduce risk, study finds
The study is the first to look at large numbers of people who fell ill with COVID but not sick enough to go the hospital and to follow them over time.
Delay in COVID vaccines for kids upset parents. Experts say it was the right thing to do.
The FDA won’t have enough data until the spring to judge whether a vaccine is safe and effective for young children, experts tell USA TODAY.
Can Biden’s ‘Cancer Moonshot’ succeed? It’s possible, experts say, but it will take more than words
Experts are thrilled by Biden’s pledge to cut the cancer death rate in half in 25 years, but they say it will take more money and greater equity.
Omicron’s new variant cousin, BA.2, has arrived in the US. But don’t panic yet, experts say.
Cases of omicron BA.2 have been reported in at least four states – California, New Mexico, Texas and Washington – and on three other continents.
Pfizer and BioNTech announce plans to test omicron-specific COVID-19 vaccine in adult trials
Pfizer and BioNTech will conduct three simultaneous trials in adults to determine if an omicron-specific vaccine is more effective than current shots.
Beyond Aduhelm: Why experts have never felt more optimistic about Alzheimer’s treatments
Even as the controversial new drug Aduhelm offers hope for those with Alzheimer’s, researchers are exploring new kinds of treatment approaches.
‘The new heart is still a rock star’: Man doing well after receiving first heart from gene-edited pig
Dave Bennett, 57, who received the first heart transplant from a genetically modified pig, is breathing on his own, and speaking with a quiet voice.